Advised the owners of MediaMonks on its sale to S4 Capital, read more.
Represented new investors INKEF Capital and Sectoral Asset Management as well as existing investors Sofinnova Ventures and Ysios Capital in respect of the USD 50 million Series B financing round of BioClin Therapeutics. Other investors include HealthCap, Tekla Capital Management funds and Life Sciences Partners (LSP).
Assisted shareholders with the sale to Inflexion Private Equity of Calco Group B.V. (“Calco”), a leading Dutch provider of IT recruitment and training services and specialised in staffing of junior IT personnel to large blue-chip corporates, operating primarily within the finance and insurance sectors with clients including the main banks and the top insurance companies in the Netherlands.
Represented Gilde Healthcare and key management (sellers) in the auction sale of ViroClinics Biosciences B.V. to Parcom Capital, a leading mid-market private equity firm in the Benelux, as well key management in their continuing investment in ViroClinics post-closing.
Advised A-Gas on the acquisition of Netherlands’ reclamation business BTC.
Represented Breath Therapeutics on EUR 43.5m Series A financing round by Gimv, Sofinnova Partners and Gilde Healthcare.
Show 4 more
Sofinnova Ventures & Ysios Capital
Represented Sofinnova Ventures and Ysios Capital as lead investors in the USD 30 million Series B Financing round of BioClin Therapeutics.